118 related articles for article (PubMed ID: 6854139)
1. Dimethyl sulfoxide inhibits bioactivation of sulindac.
Swanson BN; Boppana VK; Vlasses PH; Rotmensch HH; Ferguson RK
J Lab Clin Med; 1983 Jul; 102(1):95-101. PubMed ID: 6854139
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of sulindac metabolism by dimethyl sulfoxide in the rat.
Swanson BN; Mojaverian P; Boppana VK
J Toxicol Environ Health; 1983; 12(2-3):213-22. PubMed ID: 6655731
[TBL] [Abstract][Full Text] [Related]
3. Effect of dimethyl sulfoxide on sulindac disposition in rats.
Swanson BN; Mojaverian P; Boppana VK; Dudash MR
Drug Metab Dispos; 1981; 9(6):499-502. PubMed ID: 6120805
[TBL] [Abstract][Full Text] [Related]
4. Kinetics of the tissue distributions of sulindac and metabolites. Relevance to sites and rates of bioactivation.
Duggan DE; Hooke KF; Hwang SS
Drug Metab Dispos; 1980; 8(4):241-6. PubMed ID: 6105058
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetics of graded oral doses of sulindac in man.
Mattila J; Mäntylä R; Vuorela A; Lamminsivu U; Männistö P
Arzneimittelforschung; 1984; 34(2):226-9. PubMed ID: 6539116
[TBL] [Abstract][Full Text] [Related]
6. Influence of cholestyramine resin administration on single dose sulindac pharmacokinetics.
Malloy MJ; Ravis WR; Pennell AT; Hagan DR; Betagari S; Doshi DH
Int J Clin Pharmacol Ther; 1994 Jun; 32(6):286-9. PubMed ID: 7921528
[TBL] [Abstract][Full Text] [Related]
7. Sulindac: therapeutic implications of the prodrug/pharmacophore equilibrium.
Duggan DE
Drug Metab Rev; 1981; 12(2):325-37. PubMed ID: 7040018
[TBL] [Abstract][Full Text] [Related]
8. Biotransformation of sulindac in end-stage renal disease.
Gibson TP; Dobrinska MR; Lin JH; Entwistle LA; Davies RO
Clin Pharmacol Ther; 1987 Jul; 42(1):82-8. PubMed ID: 3595070
[TBL] [Abstract][Full Text] [Related]
9. Dimethyl sulfoxide inhibits metabolic activation of sulindac.
Swanson BN; Mojaverian P; Boppana VK; Vlasses PH; Ferguson RK
Ann N Y Acad Sci; 1983; 411():381-2. PubMed ID: 6576719
[No Abstract] [Full Text] [Related]
10. Thioredoxin-dependent sulfoxide reduction by rat renal cytosol.
Anders MW; Ratnayake JH; Hanna PE; Fuchs JA
Drug Metab Dispos; 1981; 9(4):307-10. PubMed ID: 6114827
[TBL] [Abstract][Full Text] [Related]
11. Sulfoxide reduction. In vitro reduction of sulindac by rat hepatic cytosolic enzymes.
Ratnayake JH; Hanna PE; Anders MW; Duggan DE
Drug Metab Dispos; 1981; 9(2):85-7. PubMed ID: 6113122
[TBL] [Abstract][Full Text] [Related]
12. Renal metabolism of sulindac: functional implications.
Miller MJ; Bednar MM; McGiff JC
J Pharmacol Exp Ther; 1984 Nov; 231(2):449-56. PubMed ID: 6436473
[TBL] [Abstract][Full Text] [Related]
13. Identification of the biologically active form of sulindac.
Duggan DE; Hooke KF; Risley EA; Shen TY; Arman CG
J Pharmacol Exp Ther; 1977 Apr; 201(1):8-13. PubMed ID: 850147
[TBL] [Abstract][Full Text] [Related]
14. Sulindac metabolism: the importance of an intact colon.
Strong HA; Warner NJ; Renwick AG; George CF
Clin Pharmacol Ther; 1985 Oct; 38(4):387-93. PubMed ID: 4042521
[TBL] [Abstract][Full Text] [Related]
15. Sulindac disposition when given once and twice daily.
Swanson BN; Boppana VK; Vlasses PH; Holmes GI; Monsell K; Ferguson RK
Clin Pharmacol Ther; 1982 Sep; 32(3):397-403. PubMed ID: 7049504
[TBL] [Abstract][Full Text] [Related]
16. Sulfone metabolite of sulindac inhibits mammary carcinogenesis.
Thompson HJ; Jiang C; Lu J; Mehta RG; Piazza GA; Paranka NS; Pamukcu R; Ahnen DJ
Cancer Res; 1997 Jan; 57(2):267-71. PubMed ID: 9000566
[TBL] [Abstract][Full Text] [Related]
17. Effects of age and disease on the pharmacokinetics and pharmacodynamics of sulindac.
Sitar DS; Owen JA; MacDougall B; Hunter T; Mitenko PA
Clin Pharmacol Ther; 1985 Aug; 38(2):228-34. PubMed ID: 4017423
[TBL] [Abstract][Full Text] [Related]
18. Nonsteroidal anti-inflammatory effect of sulindac sulfoxide and sulfide on gastric mucosa.
Graham DY; Smith JL; Holmes GI; Davies RO
Clin Pharmacol Ther; 1985 Jul; 38(1):65-70. PubMed ID: 3874038
[TBL] [Abstract][Full Text] [Related]
19. Analysis of sulindac and metabolites in plasma and urine by high-performance liquid chromatography.
Stubbs RJ; Ng LL; Entwistle LA; Bayne WF
J Chromatogr; 1987 Jan; 413():171-80. PubMed ID: 3558666
[TBL] [Abstract][Full Text] [Related]
20. Peripheral neuropathy after concomitant dimethyl sulfoxide use and sulindac therapy.
Reinstein L; Mahon R; Russo GL
Arch Phys Med Rehabil; 1982 Nov; 63(11):581-4. PubMed ID: 6291491
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
